CS logo
small CS logo
Oncology Hematology Care, Inc.

Cincinnati, Ohio, United States
Cancer treatment center in Cincinnati, Ohio
5053 Wooster Rd, Cincinnati, OH 45226

About Oncology Hematology Care, Inc.


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
SCRI Development Innovations, LLC
67
National Cancer Institute (NCI)
36
SWOG Cancer Research Network
20
Hoffmann-La Roche
16
Alliance for Clinical Trials in Oncology
11
Bristol-Myers Squibb
10
Celgene
9
Eli Lilly and Company
8
Amgen
7
ECOG-ACRIN Cancer Research Group
7
Incyte Corporation
7
Total Rows: 78

Clinical Trials at Oncology Hematology Care, Inc.


During the past decade, Oncology Hematology Care, Inc. conducted 106 clinical trials. In the 10-year time frame, 106 clinical trials started and 151 clinical trials were completed, i.e. on average, 142.5% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 67 clinical trials were completed. i.e. 304.5% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years3434171714148811117712123310101313212119192121202024241515Started TrialsCompleted Trails2015201620172018201920202021202202040
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum
1997-09-01
Unknown status
100
Combination Chemotherapy Plus Rituximab in Treating Patients With Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
1999-12-01
Unknown status
Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
2000-12-04
2014-03-17
Completed
2,104
Idiotype Vaccine for Low-Grade Non-Hodgkin's Lymphoma
2001-03-01
Unknown status
22
Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.
Completed
A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes
2001-08-01
2004-02-01
Completed
220
TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer
2003-06-01
2006-12-01
Completed
440
Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer
2005-05-01
2009-01-01
Completed
37

Rows per page:

1–100 of 301

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Oncology Hematology Care, Inc." #1 sponsor was "SCRI Development Innovations, LLC" with 67 trials, followed by "National Cancer Institute (NCI)" with 36 trials sponsored, "SWOG Cancer Research Network" with 20 trials sponsored, "Hoffmann-La Roche" with 16 trials sponsored and "Alliance for Clinical Trials in Oncology" with 16 trials sponsored. Other sponsors include 146 different institutions and companies that sponsored additional 78 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Hematology Care, Inc." #1 collaborator was "National Cancer Institute (NCI)" with 45 trials as a collaborator, "Genentech, Inc." with 19 trials as a collaborator, "Bristol-Myers Squibb" with 12 trials as a collaborator, "Eli Lilly and Company" with 10 trials as a collaborator and "Novartis" with 10 trials as a collaborator. Other collaborators include 104 different institutions and companies that were collaborators in the rest 61 trials.
Created with Highcharts 11.1.0Top Leading SponsorsSCRI DevelopmentInnovations, LLC: 67SCRI DevelopmentInnovations, LLC: 67National CancerInstitute (NCI): 36National CancerInstitute (NCI): 36SWOG Cancer ResearchNetwork: 20SWOG Cancer ResearchNetwork: 20Hoffmann-La Roche: 16Hoffmann-La Roche: 16Alliance for ClinicalTrials in Oncology: 11Alliance for ClinicalTrials in Oncology: 11Bristol-Myers Squibb: 10Bristol-Myers Squibb: 10Celgene: 9Celgene: 9Eli Lilly and Company: 8Eli Lilly and Company: 8Amgen: 7Amgen: 7ECOG-ACRIN CancerResearch Group: 7ECOG-ACRIN CancerResearch Group: 7

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 45National CancerInstitute (NCI): 45Genentech, Inc.: 19Genentech, Inc.: 19Bristol-Myers Squibb: 12Bristol-Myers Squibb: 12Eli Lilly and Company: 10Eli Lilly and Company: 10Novartis: 10Novartis: 10GlaxoSmithKline: 9GlaxoSmithKline: 9Bayer: 7Bayer: 7Canadian Cancer Trials Group: 6Canadian Cancer Trials Group: 6NRG Oncology: 6NRG Oncology: 6Merck Sharp & Dohme LLC: 5Merck Sharp & Dohme LLC: 5

Clinical Trials Conditions at Oncology Hematology Care, Inc.


According to Clinical.Site data, the most researched conditions in "Oncology Hematology Care, Inc." are "Breast Cancer" (24 trials), "Colorectal Cancer" (9 trials), "Metastatic Breast Cancer" (9 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials) and "Lung Cancer" (8 trials). Many other conditions were trialed in "Oncology Hematology Care, Inc." in a lesser frequency.

Clinical Trials Intervention Types at Oncology Hematology Care, Inc.


Most popular intervention types in "Oncology Hematology Care, Inc." are "Drug" (279 trials), "Other" (68 trials), "Biological" (46 trials), "Procedure" (20 trials) and "Radiation" (10 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (42 trials), "Carboplatin" (32 trials), "Placebo" (30 trials), "Docetaxel" (27 trials) and "Bevacizumab" (21 trials). Other intervention names were less common.

Clinical Trials Genders at Oncology Hematology Care, Inc.


The vast majority of trials in "Oncology Hematology Care, Inc." are 249 trials for "All" genders, 42 trials for "Female" genders and 10 trials for "Male" genders.

Clinical Trials Status at Oncology Hematology Care, Inc.


Currently, there are NaN active trials in "Oncology Hematology Care, Inc.". undefined are not yet recruiting, 29 are recruiting, 72 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 158 completed trials in Oncology Hematology Care, Inc., undefined suspended trials, and 37 terminated clinical trials to date.
Out of the total trials that were conducted in Oncology Hematology Care, Inc., 34 "Phase 1" clinical trials were conducted, 180 "Phase 2" clinical trials and 108 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 180Phase 2: 180Phase 3: 108Phase 3: 108Phase 1: 34Phase 1: 34Not Applicable: 2Not Applicable: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 158Completed: 158Active, not recruiting: 72Active, not recruiting: 72Terminated: 37Terminated: 37Recruiting: 29Recruiting: 29Unknown status: 4Unknown status: 4Enrolling by invitation: 1Enrolling by invitation: 1

Departments of Oncology Hematology Care, Inc.


Oncology Hematology Care, Inc. has several departments that took part in Clinical trials: "Oncology Hematology Care Inc-Blue Ash" - 96 trials, "Oncology Hematology Care Inc-Healthplex" - 85 trials, "Oncology Hematology Care Inc-Mercy West" - 80 trials, "Oncology Hematology Care Inc-Eden Park" - 77 trials, "Oncology Hematology Care Inc-Kenwood" - 162 trials, "Oncology Hematology Care, Inc." - 3 trials, "Oncology Hematology Care - SCRI" - 2 trials